We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -7.74 | -6.91071428571 | 112 | 113.7 | 100.9399 | 4680705 | 105.60023371 | CS |
4 | 16.9 | 19.3452380952 | 87.36 | 114.25 | 85.53 | 4648264 | 100.12374853 | CS |
12 | 7.88 | 8.17597011828 | 96.38 | 115.97 | 84.06 | 4579747 | 101.16928578 | CS |
26 | 1.95 | 1.90597204574 | 102.31 | 115.97 | 62.55 | 4546629 | 91.87876846 | CS |
52 | -45.75 | -30.4979668022 | 150.01 | 163.24 | 62.55 | 4057612 | 106.35752121 | CS |
156 | -38.8 | -27.1214874878 | 143.06 | 497.17 | 62.55 | 7183590 | 218.42985448 | CS |
260 | 81.79 | 363.996439697 | 22.47 | 497.17 | 11.54 | 8746657 | 147.5930938 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |